NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Differential Bio

Differential Bio

Private
FeldkirchenHealthcare & Life Scienceshttps://www.differential.bio/

Last Round

Pre Seed

Mar 26, 2025

Total Funding Raised

$2.2M

Company Overview

Differential Bio is a biotechnology company that has developed a virtual scale-up platform integrating microbiology, lab automation, and artificial intelligence to optimize and accelerate bioprocesses for the food, cosmetics, and specialty chemicals industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing, Industrial Robotics, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

bioprocess optimizationfermentation optimizationin-silico experimentsdigital biologyhigh-throughput screeningHTSrobotic lab automationmicrobial modelingbiomanufacturingvirtual scale-uplab-as-a-servicesynthetic biologybiotech SaaSpredictive analyticsAI-driven R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Differential Bio Comps

Public and private peers based on sector, stage, and business model.

Differential Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Differential Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 26, 2025

Key People

Founding team and executive leadership

Martin Patz

Co-Founder And Chief Technology Officer

Founding Team

Chris Spier

Co-Founder Chief Executive Officer

Founding Team

Differential Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 27, 2025

    Added Carbon13 group, a venture capital firm, as a customer.

Differential Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Differential Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Differential Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersFeldkirchen
Employee Range18
Year Founded2024
Last FundingMar 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.